Cantor Fitzgerald initiated coverage of Septerna (SEPN) with an Overweight rating and $50 price target Septerna’s powerful platform enables ...

An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in their differentiation process. The findings, published in Nature Communications ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...